Burning mouth syndrome responsive to pramipexol
- PMID: 18219443
- PMCID: PMC3476177
- DOI: 10.1007/s10194-008-0003-4
Burning mouth syndrome responsive to pramipexol
Abstract
Burning mouth syndrome (BMS) is characterized by burning discomfort or pain in otherwise normal oral mucosa. It is usually refractory. Treatment modalities are scarce. Herein we report one case of primary disabling BMS, previously refractory to multiple regimens, with complete and persistent improvement with pramipexol, a nonergot dopamine agonist which has high selectivity for dopaminergic D2 receptors. We discuss potential pathophysiological implications of our findings.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
